NU Skin Enterprises Inc
NYSE:NUS
NU Skin Enterprises Inc
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. The company is headquartered in Provo, Utah and currently employs 4,600 full-time employees. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The firm operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. The company is headquartered in Provo, Utah and currently employs 4,600 full-time employees. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The firm operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.
Revenue: Q3 revenue was $364 million, landing within guidance.
EPS: Earnings per share of $0.34 reached the high end of guidance.
Guidance Update: Full-year revenue guidance narrowed to $1.48–$1.51 billion, with the EPS low end raised; high end remains $3.25.
Profitability: Gross margin improved for the fifth straight quarter; cost controls and product mix supported higher operating margin.
Growth Drivers: Latin America grew 53% YoY; Prysm iO device and India market entry set up for 2026 expansion.
North America: Business model evolving due to industry changes; aiming for a rebalance between beauty and wellness.
Cash & Capital Return: Ended Q3 with $252 million in cash, reduced debt, continued dividends and share buybacks.
